Pelaia, Girolamo, et al. “Pharmacologic Rationale, Efficacy and Safety of the Fixed-Dose Co-Formulation of Indacaterol and Glycopyrronium”. Multidisciplinary Respiratory Medicine, vol. 9, no. 1, Dec. 2014, https://doi.org/10.4081/mrm.2014.399.